Synthego Announces Successful Close of Acquisition by Perceptive Advisors
REDWOOD CITY, Calif., July 21, 2025 /PRNewswire/ — Synthego, a leading provider of CRISPR solutions, today announced the successful closing of the acquisition... Read more.
S.A.F.E. Structure Designs Achieves AS9100D and ISO 9001:2015 Certification, Advancing Strategic Readiness as a Key U.S. Defense Contractor
LAS VEGAS, July 21, 2025 /PRNewswire/ — S.A.F.E. Structure Designs, a leading U.S. defense contractor of ergonomic, safety-first support equipment for military... Read more.
Multiplier Wins Gold and Silver Stevie® Awards for Redefining Global Hiring
The company was awarded Gold for HR Technology Solution Provider of the Year and Silver for Global HR Solution Provider of the Year. NEW YORK, July 21, 2025 /PRNewswire/... Read more.
S&P Dow Jones Indices to Acquire ARC Research, Expanding Wealth Data and Benchmarking Capabilities
LONDON, July 21, 2025 /PRNewswire/ — S&P Dow Jones Indices (“S&P DJI”), a division of S&P Global (NYSE: SPGI) and the world’s... Read more.
PDFgear Scan, Finally, a Truly Free AI Scanner App for All
LOS ANGELES, July 21, 2025 /PRNewswire/ — PDFgear today launched PDFgear Scan, the world’s first free AI-powered scanner app. The app turns paper... Read more.
Epic MyChart Bedside TV Now Runs Natively on hellocare.ai Devices, Available in Epic Toolbox
CLEARWATER, Fla., July 21, 2025 /PRNewswire/ — hellocare.ai, the leading AI-assisted virtual care delivery and patient engagement platform transforming... Read more.
Protalix BioTherapeutics Appoints Gilad Mamlok as its New Senior Vice President and Chief Financial Officer
CARMIEL, Israel, July 21, 2025 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development,... Read more.
Hyperscale Data Targets Full Buildout of 340 MW Michigan AI Data Center Campus in 2029
Files $125 Million Shelf Registration to Provide Long-Term Financial Flexibility; No Immediate Capital Raise Planned LAS VEGAS, July 21, 2025 /PRNewswire/ —... Read more.
Nuvalent Announces Initiation of ALKAZAR Phase 3 Randomized, Controlled Trial Evaluating Neladalkib for Patients with TKI-naïve ALK-positive NSCLC
CAMBRIDGE, Mass., July 21, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted... Read more.
DCA Opens Today to Strengthen Asia’s Data Centre Network
HONG KONG, July 21, 2025 /PRNewswire/ — Data Center Asia (DCA) debuts today at AsiaWorld-Expo, Hong Kong, marking the exciting launch of a new force in the... Read more.